VCAM1 and neoplasm: Patient-derived CAFs can induce the adhesion and enrichment of monocytes by upregulating the expression of VCAM1 and the secretion of IL-8 and promote the recruitment of M2 macrophages into the tumour microenvironment, which together inhibit the function of NK cells (Zhang et al. 2019).